Research on natural products from traditional Chinese medicine in the treatment of myocardial ischemia-reperfusion injury

被引:8
|
作者
Bu, Wenyu [1 ]
Zhang, Zhaoyang [1 ]
Ocansey, Dickson Kofi Wiredu [2 ,5 ]
Yu, Zhihua [3 ]
Yang, Xiao [1 ,4 ]
Liu, Zhitong [1 ]
Wang, Xinyu [1 ]
Ke, Yuhe [1 ,3 ]
机构
[1] Hubei Univ Chinese Med, First Clin Med Inst, Wuhan 430060, Hubei, Peoples R China
[2] Jiangsu Univ, Sch Med, Key Lab Med Sci & Lab Med Jiangsu Prov, Zhenjiang 212013, Jiangsu, Peoples R China
[3] Wuhan Hosp Tradit Chinese & Western Med, Dept Cardiol, Wuhan 430022, Hubei, Peoples R China
[4] Taicang Hosp Tradit Chinese Med, Suzhou 215400, Jiangsu, Peoples R China
[5] Univ Cape Coast, Univ Hlth Serv, Cape Coast, Ghana
来源
关键词
Myocardial ischemia-reperfusion injury; traditional Chinese medicine therapy; ingredients of traditional Chinese medicine; compound Chinese medicine; ISCHEMIA/REPERFUSION INJURY; CELL-DEATH; OXIDATIVE STRESS; AUTOPHAGY; PROTECTS; LUTEOLIN; HEART; RATS; CARDIOPROTECTION; ATTENUATION;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Myocardial ischemia-reperfusion injury (MIRI) is a complicated pathologic process that involves multiple factors including oxidative stress (free radical damage), inflammatory response, calcium overloading, and apoptosis in cardiomyocytes. According to Traditional Chinese Medicine (TCM), MIRI belongs to the categories of "chest numbness", "palpitations" and "angina pectoris". Present data indicate that the application of TCM in myocardial ischemia-reperfusion injury is promising and continues to attract research attention. While the efficacy of Chinese herbal medicine has been well-proven, the underlying molecular mechanisms remain elusive. The common proven mechanisms of Chinese herbal medicine in the treatment of MIRI include regulating lipid metabolism, protecting mitochondria, and improving energy metabolism, attenuating calcium (Ca2+) overload, scavenging oxygen free radicals, inhibiting apoptosis, and reducing autophagy. Others are the regulation of inflammatory cytokine expressions and healing of inflammatory lesions, modulation of cell signaling pathways, improvement of endothelial cell function, and protection of myocardial cells. In this review, we highlight recent studies that focus on elucidating these molecular mechanisms and the therapeutic effects of natural compounds deriving from TCM in MIRI, to ascertain the research progress made and the prospects in this field.
引用
收藏
页码:1952 / 1968
页数:17
相关论文
共 50 条
  • [31] AMELIORATING EFFECTS OF CARDIOTONIC PILLS,A COMPOUND CHINESE MEDICINE ON MYOCARDIAL MICROCIRCULATORY DISTURBANCE AND MYOCARDIAL INJURY AFTER ISCHEMIA-REPERFUSION
    Jing-Yan Han
    World Journal of Traditional Chinese Medicine, 2015, (04) : 77 - 77
  • [32] Research progress on natural products from traditional Chinese medicine in treatment of Alzheimer's disease
    Gao, Jianjun
    Inagaki, Yoshinori
    Li, Xuan
    Kokudo, Norihiro
    Tang, Wei
    DRUG DISCOVERIES AND THERAPEUTICS, 2013, 7 (02): : 46 - 57
  • [33] Acute and long-term cardioprotective effects of the Traditional Chinese Medicine MLC901 against myocardial ischemia-reperfusion injury in mice
    Vincent, Anne
    Covinhes, Aurelie
    Barrere, Christian
    Gallot, Laura
    Thoumala, Soulit
    Piot, Christophe
    Heurteaux, Catherine
    Lazdunski, Michel
    Nargeot, Joel
    Barrere-Lemaire, Stephanie
    SCIENTIFIC REPORTS, 2017, 7
  • [34] Acute and long-term cardioprotective effects of the Traditional Chinese Medicine MLC901 against myocardial ischemia-reperfusion injury in mice
    Anne Vincent
    Aurélie Covinhes
    Christian Barrère
    Laura Gallot
    Soulit Thoumala
    Christophe Piot
    Catherine Heurteaux
    Michel Lazdunski
    Joël Nargeot
    Stéphanie Barrère-Lemaire
    Scientific Reports, 7
  • [35] Progress in Chinese medicine monomers and their nanoformulations on myocardial ischemia/reperfusion injury
    Zhou, Yanrong
    Wang, Li
    Sun, Lina
    Tan, Rui
    Wang, Zheng
    Pei, Renjun
    JOURNAL OF MATERIALS CHEMISTRY B, 2025, 13 (04) : 1159 - 1179
  • [36] Advanced research on the regulated necrosis mechanism in myocardial ischemia-reperfusion injury
    Deng, Jianying
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 334 : 97 - 101
  • [37] Insight into myocardial ischemia-reperfusion injury from the perspective of ferroptosis
    Huang, Xia
    Wang, Yanni
    Cui, Xiangrong
    Yan, Qin
    Xue, Tingting
    Jing, Xuan
    PERFUSION-UK, 2024,
  • [38] Clarithromycin attenuates myocardial ischemia-reperfusion injury
    Nakajima, Takuya
    Hishikari, Keiichi
    Ogawa, Masahito
    Watanabe, Ryo
    Suzuki, Jun-ichi
    Nagashima, Ayako
    Masumura, Mayumi
    Takayama, Kiyoshi
    Hirata, Yasunobu
    Nagai, Ryozo
    Isobe, Mitsuaki
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (09) : 881 - 893
  • [39] Trimetazidine ameliorates myocardial ischemia-reperfusion injury
    He, Chuanbo
    Cao, Shujun
    Tong, Zichuan
    Wang, Wenbin
    Zhang, Yin
    Guo, Changlei
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 31 (04) : 1691 - 1696
  • [40] The Hedgehog morphogen in myocardial ischemia-reperfusion injury
    Bijlsma, Maarten F.
    Spek, C. Arnold
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2010, 235 (04) : 447 - 454